Novelty Pharma

What Novelty Pharma does

Novelty Pharma is a Swiss-headquartered pharmaceutical company specializing in effervescent tablet technology, founded in 1998 and operating from Cadempino, Lugano. The company focuses on three oral solid dosage forms — effervescent tablets, orodispersible tablets, and soluble granules — built around a proprietary manufacturing technology stack that includes HET (complete granulation), UNISTACK (partial granulation for cost efficiency), UCT (Ultra Compressed Technology that triples active-ingredient density per tablet), and the EFFERGIZE concept for converting complex molecules into effervescent form. With 51–100 employees and 25+ years of focused R&D, the company operates from dual manufacturing jurisdictions (Switzerland headquarters and India since 2011) and serves more than 40 countries.

The business operates across three revenue streams: (1) contract manufacturing of fully customized effervescent tablets for B2B pharmaceutical clients, with end-to-end customization across technology, format, dosage, ingredients, flavor, and packaging; (2) licensing of internally developed EU CTD pharmaceutical dossiers and nutraceutical dossiers to partners, enabling clients to obtain local Marketing Authorizations under their own branding while Novelty Pharma supplies finished product; and (3) sale of market-ready branded products under the Novelty Engenerics line (generic effervescent drugs) and the Fast & Up consumer brand (sports, immunity, everyday, and beauty supplements distributed in 20+ countries). GTM is sales-led via direct B2B relationships supported by regional contacts in Italy, India, Greece, and the UK, with pricing on a quote-based, multi-year contract manufacturing model. The company is Swiss Medic certified and holds a 2003 Swiss patent for branched-chain amino acid formulations.

Name

Novelty Pharma

Legal name

Novelty Pharma

Website

https://noveltypharma.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1–10 employees

Short description

Novelty Pharma is a Swiss pharmaceutical contract manufacturer and dossier licensor specializing in proprietary effervescent tablet technology (HET, UNISTACK, UCT). It serves B2B pharmaceutical, nutraceutical, and cosmetics clients in 40+ countries, and distributes branded supplements (Fast & Up) in 20+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

akta.pro secondary industries

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Health, Wellness & Pharmacy Online Retailers (CRAFADAG)

Keywords

• Effervescent tablet manufacturing
• Contract pharmaceutical manufacturing
• Pharmaceutical dossier licensing
• Nutraceutical supplements
• Effervescent drug delivery

Headquarters

HQ city

Cadempino

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Contract Manufacturing: Novelty Pharma manufactures customized effervescent tablets for B2B clients, offering tailor-made production where clients can customize technology (HET or UNISTACK), format (tube or strip), dosage, ingredients, shape, size, flavors, quantity, and packaging. The company licenses its internally developed dossiers to partners so they can register and obtain Marketing Authorization for products in their country, branding with their own logo. The client becomes the dossier owner while Novelty Pharma acts as manufacturer or supplier of finished product.
2. Market-Ready Product Sales: Sale of pre-formulated effervescent tablets from the Novelty Engenerics line including generic pharmaceuticals (Vitamin C, Calcium+Vitamin D3, Magnesium, N-Acetylcysteine) and dietary supplements (Sports, Immunity, Beauty, Daily Wellness categories). Customers can customize quantity and packaging.
3. Dossier Licensing: The company licenses pharmaceutical dossiers (EU CTD format) and nutraceutical dossiers developed internally to partners for product registration, ensuring compliance with European and international regulations. The regulatory team monitors pre- and post-product approval processes.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

Novelty Pharma manufactures customized effervescent tablets for B2B clients using proprietary HET and UNISTACK technologies, offering tailor-made production with full customization of technology, format, dosage, ingredients, flavors, and packaging. The company also sells market-ready generic and nutraceutical effervescent products under its Novelty Engenerics, Fast & Up, and Novelty Life brands, and licenses internally developed pharmaceutical dossiers (EU CTD format) to partners for local product registration and Marketing Authorization.

Product overview

Novelty Pharma is a Swiss pharmaceutical company specializing in effervescent tablet development and manufacturing with over 25 years of experience. The company operates two distinct product/service offerings: (1) Market-ready products under the Novelty Engenerics brand (generic drugs for acute conditions) and multiple supplement lines including Sports, Everyday/Quotidianità, Immunity, and Beauty & Wellness categories; and (2) Tailor Made custom manufacturing services using proprietary HET and UNISTACK technologies. The company also licenses its internally-developed pharmaceutical dossiers to partners for local market registration. Key technologies include HET (complete granulation for superior quality) and UNISTACK (partial granulation for efficiency). Notable brands include Fast & Up (sports supplements, India market leader distributed in 20+ countries) and Novelty Life (therapeutic formulas with UCT Technology). Products are available in tube and strip formats with customizable flavors, packaging, and marketing support.

Differentiator

Problem solved

Functional benefit

Brands

• Fast & Up: Flagship effervescent supplement brand launched in 2015, distributed in more than 20 countries worldwide. First comprehensive range of effervescent supplements in India.
• Novelty Engenerics
• Novelty Life

Products and services

• Tailor Made Manufacturing Service Customized effervescent tablet manufacturing service offering complete customization including technology selection (HET or UNISTACK), format (tube or strip), dosage, ingredients, shape, size, flavors, quantity, and packaging, with full regulatory support for B2B pharmaceutical and nutraceutical companies.
• Novelty Engenerics Market-ready generic pharmaceuticals in effervescent formulation (Vitamin C, Calcium + Vitamin D3, Magnesium, N-Acetylcysteine 200/600 mg) for rapid absorption and immediate action in acute conditions such as pain, allergies, and respiratory diseases.
• Sports Supplements Line Complete line of sports nutrition effervescent supplements including L-Arginine, Pre Workout, Energyboost, Rapid Creatine, L-Carnitine, Amino Acids, Electrolytes, Probiotics, and Taurine for athletic performance and recovery.
• Quotidianità (Everyday) Supplements Line Daily health supplements including Apple Cider Vinegar, Glucosamine + Chondroitin, Magnesium + Zinc, Melatonin + L-Theanine, and comprehensive Multivitamin formulas for general wellness and daily nutrition.
• Immunity Supplements Line Immune support supplements including Vitamin C + D3 + Zinc, Glutathione + Vitamin C, Elderberry with Anthocyanins, and N-Acetylcysteine + Vitamin C for respiratory tract and immune system support.
• Beauty and Wellness Line Beauty and wellness supplements including Biotin with Selenium, plant-based Vegan Collagen builder blend, and Anti-Hangover formulas with Taurine, Creatine, and B vitamins for hair, nails, skin, and recovery support.
• Fast & Up Brand Flagship consumer brand offering a comprehensive range of effervescent supplements, launched originally in 2003 with the first Swiss patent for branched-chain amino acids. Now one of the leading supplement brands in India, distributed in 20+ countries.
• Novelty Life Line Therapeutic product line featuring innovative formulas developed with UCT Technology (Ultra Compressed Technology) that triples active ingredient content per effervescent tablet.
• Pharmaceutical Dossier Licensing Licensing of pharmaceutical dossiers (EU CTD format) and nutraceutical dossiers developed internally to partners for product registration, enabling compliance with European and international regulations and allowing partners to become dossier owners with their own branding.

Quantifiable outcome

• Tripled active ingredient content per tablet using UCT Technology
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered minor and core.

• Taiwanese Registration PartnerminorChannel Partner/ Reseller/ Distributor · 1 January 2024In 2024, Novelty Pharma obtained its first registration in Taiwan for N-Acetylcysteine (NAC) 600mg effervescent tablets.
• Ukrainian Market PartnerminorChannel Partner/ Reseller/ Distributor · 1 January 2019In 2019, Novelty Pharma completed development of an effervescent dietary supplement enriched with Vitamin C, D and Zinc, which served as the launchpad for their first foray into the Ukrainian market.
• South African Licensing PartnerminorOEM/ Whitelabel/ Licensing Partner · 1 January 2017In 2017, Novelty Pharma initiated its first expansion into South Africa through a partnership for licensing N-Acetylcysteine 600mg effervescent tablets.
• Indian Operations (Office, Lab, Manufacturing Site)coreStrategic or Co-development Partner · 1 January 2011Novelty Pharma expanded into the Indian effervescent market in 2011, opening an office, development laboratory, and manufacturing site. The technology continues to evolve, demonstrating ability to create and produce stable products even in unfavorable conditions such as IVB zone.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Hermes Arzneimittel: German specialty pharmaceutical company that develops and markets effervescent tablets (vitamins, minerals, OTC remedies) under its own brands. Highly comparable to Novelty Pharma's Novelty Engenerics line in product format and category focus, though it operates more as a branded specialist than a pure contract manufacturer.
• Siegfried Holding: Swiss-listed pharmaceutical contract manufacturer offering APIs and finished dosage forms including tablets. Same Swiss origin, GMP-regulated contract-manufacturing model, and customer base of branded pharma companies make it a direct peer, though at materially larger scale than Novelty Pharma.
• Hovione: Portuguese pharmaceutical CDMO focused on APIs and particle-engineered drug products, serving innovator and generic pharma clients worldwide. Direct peer in the pharmaceutical contract-development-and-manufacturing space, though Novelty Pharma's dosage-form focus is narrower.
• Recipharm: Swedish-headquartered pharmaceutical CDMO with a broad European manufacturing footprint covering solid, semi-solid, and sterile dosage forms. Directly comparable contract-manufacturing model serving B2B pharmaceutical clients across multiple therapeutic areas.
• Aenova Group: One of Europe's largest pharmaceutical contract manufacturers producing solid, semi-solid, and liquid dosage forms for branded and generic pharma customers. Direct overlap with Novelty Pharma's B2B contract-manufacturing business model and customer type (enterprise pharma companies).
• Delpharm: French-headquartered pharmaceutical CDMO producing solid, sterile, and liquid forms for European and global branded pharma clients. Direct peer in pharmaceutical contract manufacturing serving enterprise customers across multiple European geographies.

Emerging players

• Bora Pharmaceuticals: Taiwan-listed pharmaceutical CDMO focused on oral solid dose manufacturing and serving specialty pharma clients in regulated markets. Partial overlap with Novelty Pharma's contract-manufacturing and dossier-licensing model, particularly through recent Taiwan-region registration of N-Acetylcysteine effervescent products.

Broad incumbents

• Catalent: Global pharmaceutical CDMO offering softgel, oral solid, and biologic drug-product services. Overlaps with Novelty Pharma's B2B manufacturing model and customer base but operates at much larger scale across many dosage forms.
• Lonza Group: Swiss-domiciled global pharmaceutical contract manufacturer with extensive capabilities across APIs, biologics, and drug products. Comparable as a Swiss pharmaceutical manufacturer/CDMO serving enterprise clients globally, but operates at substantially greater scale and breadth than Novelty Pharma.

Regional players

• Piramal Pharma Solutions: Indian pharmaceutical CDMO offering sterile injectables, oral solids, and API services to global pharma clients. Comparable to Novelty Pharma's India-based manufacturing operations and global B2B pharma CDMO model; less overlapping on the effervescent specialty itself.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novelty Pharma